Your browser doesn't support javascript.
loading
Permanent pacemaker use among patients with heart failure and preserved ejection fraction: Findings from the Acute Decompensated Heart Failure National Registry (ADHERE) National Registry.
Khazanie, Prateeti; Hellkamp, Anne S; Fonarow, Gregg C; Curtis, Lesley H; Al-Khatib, Sana M; Hernandez, Adrian F.
Afiliação
  • Khazanie P; Department of Medicine, University of Colorado Denver, CO.
  • Hellkamp AS; Duke Clinical Research Institute, Durham, NC.
  • Fonarow GC; Duke University School of Medicine, Durham, North Carolina; and Ahmanson-UCLA Cardiomyopathy Center, University of California, Los Angeles.
  • Curtis LH; Duke Clinical Research Institute, Durham, NC; Center for Population Health Sciences, Durham, NC; Department of Medicine, Durham, NC.
  • Al-Khatib SM; Duke Clinical Research Institute, Durham, NC; Department of Medicine, Durham, NC.
  • Hernandez AF; Duke Clinical Research Institute, Durham, NC; Center for Population Health Sciences, Durham, NC; Department of Medicine, Durham, NC. Electronic address: adrian.hernandez@duke.edu.
Am Heart J ; 198: 123-128, 2018 04.
Article em En | MEDLINE | ID: mdl-29653633
ABSTRACT

BACKGROUND:

Heart failure with preserved ejection fraction may be associated with chronotropic incompetence, but little is known about the incidence and prevalence of permanent pacemaker use in this population or factors associated with its use.

METHODS:

We analyzed patients with heart failure with preserved ejection fraction (ie, left ventricular ejection fraction greater than 40%) from the ADHERE registry (2001-2006) linked with Medicare claims. We described the use of both prevalent and incident permanent pacemakers in heart failure with preserved ejection fraction and determined factors associated with pacemaker use with logistic regression models.

RESULTS:

Among 13,881 patients with heart failure with preserved ejection fraction, 3136 (22.6%) had a permanent pacemaker, and of these patients, 636 had a permanent pacemaker implanted during hospitalization. Permanent pacemaker use was more common among older patients (81 vs 79 years; P < .001), men (38% vs 34%; P < .001), patients with atrial fibrillation (58% vs 36%; P < .001), and patients with wider QRS duration (140 ms vs 94 ms; P < .001). Rates of digoxin, aldosterone antagonist, and loop diuretic use were slightly higher in patients with a permanent pacemaker compared with patients with no permanent pacemaker. Factors associated with both prevalent and incident pacemaker use included age, fast or slow heart rate, atrial fibrillation, and lower body mass index.

CONCLUSIONS:

Use of permanent pacemakers is relatively common among patients with heart failure with preserved ejection fraction.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Marca-Passo Artificial / Volume Sistólico / Estimulação Cardíaca Artificial / Sistema de Registros / Insuficiência Cardíaca Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male País como assunto: America do norte Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Marca-Passo Artificial / Volume Sistólico / Estimulação Cardíaca Artificial / Sistema de Registros / Insuficiência Cardíaca Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male País como assunto: America do norte Idioma: En Ano de publicação: 2018 Tipo de documento: Article